Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block
NCT ID: NCT02090790
Last Updated: 2014-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2014-03-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Peripheral Nerve Blocks in Total Knee Arthroplasty
NCT07040709
The Effect of Adjuvant Dexamethasone on Postoperative Pain, Analgesic Consumption and Block Properties in SFIB
NCT05979597
Nerve Blocks With Dexamethasone and Local Anaesthetic to Improve Postoperative Analgesia
NCT02436694
Two Different Blocks for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty
NCT04286035
Femoral and Epidural Block After Total Knee Arthroplasty
NCT02115945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Dexamethasone is a glucocorticoid of high potency and frequently used perioperative.Dexamethasone to the local anaesthetic solution administered trough in femoral nerve blocks significantly prolonged the analgesic effect of the local anaesthetics used on this blocks.If the analgesic efficacy of systemic treatment with dexamethasone is similar with the use of perineural wich is the safest way should be preferred for systemic use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iv dexamethasone
perioperative 2ml 8 mg ıv dexamethasone
iv dexamethasone
2 ml 8 mg iv dexamethasone
femoral dexamethasone
femoral block was performed postoperative 30 ml 0,5 % bupivacaine added 2 ml 8 mg dexamethasone
femoral dexamethasone
2ml 8mg dexamethasone administration added 30 ml 0,5 % bupivacain
serum physiologic
serum physiologic
2 ml iv serum physiologic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iv dexamethasone
2 ml 8 mg iv dexamethasone
femoral dexamethasone
2ml 8mg dexamethasone administration added 30 ml 0,5 % bupivacain
serum physiologic
2 ml iv serum physiologic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* knee arthroplasty
* no known allergies to drugs
* ASA 1-2 patients
Exclusion Criteria
* history of chronic pain treatment
* pregnancy
* severe bronchopulmonary disease
* systemic opioid and steroid use
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmet öner
resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmet öner, recident
Role: PRINCIPAL_INVESTIGATOR
erciyes univercity
gülen güler, prof
Role: STUDY_DIRECTOR
erciyes univercity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes Univercity Hospital
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.